Drug helps preserve muscle during weight loss

3 minute read


A phase 2 trial has found a myostatin inhibitor reduces lean mass loss in patients receiving tirzepatide.


This content is for AHPRA registered professionals only.
Join Now

End of content

No more pages to load

Log In Register ×